Author

Katrine A. Taran

Baylor College of Medicine

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Plant Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1 Research Focus:perturbation response prediction· 1 Organism:plant (other)· 1 Assay:proteomics· 1

Frequent Co-Authors

Aishwarya C. Ballapuram· 1 shared Benjamin F. CravattiD· 1 shared Benjamin J. HuangiD· 1 shared Beth A. RowaniD· 1 shared Boer Xie· 1 shared Camille J. Leung· 1 shared Cana Shirley· 1 shared Carlos GuijasiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aishwarya C. Ballapuram

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Monitoring the stability of transgene expression in lettuce using the RUBY reporter.

Beth A. Rowan, Megan Reeves, Claire Hays, Cana Shirley, Wathsala Rajapakse, Katrine A. Taran, Tawni Bull, Dylan A. Wong, Richard W. Michelmore

This study evaluates three transgene expression constructs in lettuce using the RUBY reporter, finding that the LsUBI promoter/terminator provides stable, uniform expression while the AtUBI promoter/tRBCS offers an intermediate option.

Plant Cell Reports · Nov 26, 2025Peer-reviewedPlant Biology

In vivo validation of the palmitoylation cycle as a therapeutic target in NRAS-mutant cancer

Matthew Decker, Benjamin J. Huang, Timothy B. Ware, Christopher D. Boone, Michelle Tang, Julia Ybarra, Matthew J. Sale, Rony A. Francois, Aishwarya C. Ballapuram, Katrine A. Taran, Esteban Tarazona-Guzman, Pan-Yu Chen, Marcos Armendariz, Camille J. Leung, Max Harris, , Kevin Shannon

This study validates the palmitoylation cycle as a therapeutic target in NRAS-mutant cancers by showing that inhibiting ABHD17 reduces tumor growth and synergizes with MEK inhibitors.

bioRxiv · Mar 20, 2025 · PreprintCancer Biology